Breadcrumb

null Three renewed Canada Research Chairs for RI-MUHC researchers

Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs

Ahmad Haidar, PhD, Dennis Jensen, PhD, and Ian Watson, PhD, are members of the Research Institute of the McGill University Health Centre
Ahmad Haidar, PhD, Dennis Jensen, PhD, and Ian Watson, PhD, are members of the Research Institute of the McGill University Health Centre

The Honourable François-Philippe Champagne, Minister of Innovation, Science, and Industry announced on January 12 more than $151 million for science, research and engineering in Canada through the Canada Research Chairs (CRC) 2020-2 cycle. Three members of the Research Institute of the McGill University Health Centre (RI-MUHC) received renewed CRCs in this round, within the McGill cohort of nine new and eight renewed CRCs. Across the country, 188 new and renewed CRCs were supported at 43 institutions.

"We are extremely proud of our researchers' success in obtaining and renewing salary awards with the highest level of peer review in the country," said Dr. Rhian Touyz, Executive Director and Chief Scientific Officer, RI-MUHC.

Congratulations to the following RI-MUHC members:

Ahmad Haidar
Metabolic Disorders and Complications Program, RI-MUHC
Canada Research Chair in Artificial Pancreas Systems, CIHR, Tier 2

  • Research focus: developing artificial pancreas systems – medical devices that automatically regulate glucose levels and are considered the most promising therapy for type 1 diabetes.

Dennis Jensen
Translational Research in Respiratory Diseases Program, RI-MUHC
Canada Research Chair in Clinical Exercise and Respiratory Physiology, CIHR, Tier 2

  • Research focus: advancing knowledge on the mechanisms, measurement and management of activity-related breathlessness and exercise intolerance in people with chronic pulmonary disease.

Ian Watson
Cancer Research Program, RI-MUHC
Canada Research Chair in Functional Genomics of Melanoma, CIHR, Tier 2

  • Research focus: improving on diagnostic and treatment modalities for cutaneous melanoma, the deadliest form of skin cancer, using computational approaches, in vivo models and biochemical techniques studying patient samples, cell lines and melanoma mouse models.

Canada Research Chairs are some of the world’s brightest scholars and scientists who contribute to new discoveries and help us make sense of the world we live in. This cycle of chairs will see more discoveries and critical research contributions in diverse research areas such as health economics, Black studies, photonic devices, substance use and health policy research, artificial intelligence law and data governance, and ocean history and sustainability, among many others. The CRC program is a tri-agency initiative of the Social Sciences and Humanities Research Council (SSHRC), the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Institutes of Health Research (CIHR).

January 27, 2022

Related news

Federal government announces 17 Canada Research Chairs for McGill (McGill Reporter)